Citius Pharmaceuticals Inc (CTXR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select FieldsSymbol | CTXR | ELYM | GLYC | ||
Company | Citius Pharmaceuticals Inc | Eliem Therapeutics Inc | Glycomimetics Inc | ||
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | ||
Open | 0.6500 | 3.49 | 1.6800 | ||
High | 0.6864 | 4.16 | 1.7600 | ||
Low | 0.6400 | 3.32 | 1.6250 | ||
Last | 0.6648 | 3.98 | 1.6400 | ||
Change | -0.0678 | +0.59 | -0.0700 | ||
% Change | -9.25% | +17.40% | -4.09% | ||
Volume | 2,776,400 | 580,200 | 1,015,400 | ||
20-Day Average Volume | 1,352,165 | 2,198,490 | 755,765 | ||
Previous Close | 0.7326 | 3.39 | 1.7100 | ||
Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
Has Options | Yes | No | Yes | ||
Technicals | |||||
20-Day Moving Average | 0.8374 | 3.56 | 2.3230 | ||
20-Day Raw Stochastic | 5.77% | 54.68% | 0.98% | ||
20-Day Relative Strength | 40.68% | 58.72% | 30.98% | ||
Weighted Alpha | -50.99 | -2.48 | -18.76 | ||
Today's Opinion | 24% Sell | 100% Buy | 24% Sell | ||
Previous Opinion | 24% Sell | 88% Buy | 24% Sell | ||
Last Month's Opinion | 8% Buy | 72% Buy | 80% Buy | ||
Performance | |||||
5-Days | |||||
%Chg | -11.88% since 04/19/24 | +3.38% since 04/19/24 | -14.81% since 04/19/24 | ||
Low | 0.6400 on 04/26/24 | 3.32 on 04/26/24 | 1.6250 on 04/26/24 | ||
High | 0.7996 on 04/23/24 | 4.16 on 04/23/24 | 2.0500 on 04/22/24 | ||
1-Month | |||||
%Chg | -17.06% since 03/26/24 | +46.86% since 03/26/24 | -42.46% since 03/26/24 | ||
Low | 0.6400 on 04/26/24 | 2.52 on 04/05/24 | 1.6250 on 04/26/24 | ||
High | 1.0700 on 04/02/24 | 5.19 on 04/15/24 | 3.1800 on 03/27/24 | ||
3-Month | |||||
%Chg | -2.26% since 01/26/24 | +38.43% since 01/26/24 | -48.43% since 01/26/24 | ||
Low | 0.6000 on 02/08/24 | 2.52 on 04/05/24 | 1.6250 on 04/26/24 | ||
High | 1.0700 on 04/02/24 | 5.19 on 04/15/24 | 3.5000 on 01/29/24 | ||
6-Month | |||||
%Chg | -11.60% since 10/26/23 | +54.43% since 10/26/23 | +31.20% since 10/26/23 | ||
Low | 0.6000 on 02/08/24 | 2.35 on 12/11/23 | 1.1300 on 10/27/23 | ||
High | 1.0700 on 04/02/24 | 5.19 on 04/15/24 | 3.5299 on 01/23/24 | ||
Key Statistics | |||||
Market Capitalization, $K | 105,766 | 110,322 | 105,698 | ||
Shares Outstanding, K | 159,095 | 27,719 | 64,450 | ||
Annual Sales | 0 | 0 | 10,000 | ||
Annual Net Income | -32,540,000 | -35,120,000 | -36,900,000 | ||
Last Quarter Sales | 0 | 0 | 10,000 | ||
Last Quarter Net Income | -9,230,000 | -3,640,000 | -9,080,000 | ||
60-Month Beta | 1.45 | 0.51 | 2.18 | ||
Per-Share Information | |||||
Most Recent Earnings | -0.06 on 02/14/24 | -0.15 on 11/14/23 | -0.14 on 03/27/24 | ||
Latest Earnings Date | 05/10/24 | 05/09/24 | 05/09/24 | ||
Most Recent Dividend | N/A | N/A | N/A | ||
Next Ex-Dividends Date | N/A | N/A | N/A | ||
Ratios | |||||
Price/Earnings ttm | 0.00 | 0.00 | 0.00 |